Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 9 INDUSTRY 6 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Recurrence 4 Lung Neoplasms 4 Hodgkin Disease 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 2 Rhabdomyosarcoma 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma 2 Adenocarcinoma of Lung 2 Sarcoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Prostatic Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasm Metastasis 1 Melanoma 1 Familial ependymoma 1 Central Nervous System Neoplasms 1 Astrocytoma 1

Interventions

Radiotherapy 9 Radiosurgery 6 Oxaliplatin 5 Cisplatin 5 Paclitaxel 4 Capecitabine 4 Leucovorin 3 Irinotecan 3 Fluorouracil 3 Doxorubicin 3 Docetaxel 3 strontium chloride 2 regorafenib 2 pembrolizumab 2 enzalutamide 2 Zoledronic Acid 2 Temozolomide 2 Radiofrequency Ablation 2 Mitomycin 2 Methods 2 Ifosfamide 2 Gemcitabine 2 Filgrastim 2 Educational Status 2 Early Intervention, Educational 2 Bleomycin 2 Bevacizumab 2 Analgesia 2 Albumin-Bound Paclitaxel 2 trifluridine tipiracil drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Neoplasm Metastasis × Vinorelbine × Clear all

NCT02954055 2024-02-26

METEORA-II

ETOP IBCSG Partners Foundation

Phase 2 Completed

140 enrolled 11 charts

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡